Panacea Life Sciences Holdings, Inc. — Net Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/82bea46d-fa56-459a-9a61-bbef71145673/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-8.0M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-012107 |
| FY 2022 | $-9.1M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-009742 |
| FY 2021 | $-4.8M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-008215 |
| FY 2020 | $-5.2M | 2020-01-01 – 2020-12-31 | evidence 0001493152-22-008215 |
| FY 2019 | $-10.0M | 2019-01-01 – 2019-12-31 | evidence 0001654954-20-009347 |
| FY 2018 | $-4.3M | 2018-01-01 – 2018-12-31 | evidence 0001654954-19-003656 |
| FY 2017 | $-3.9M | 2017-01-01 – 2017-12-31 | evidence 0001654954-18-003508 |
| FY 2016 | $-1.6M | 2016-01-01 – 2016-12-31 | evidence 0001654954-17-002846 |
| FY 2015 | $-358.0k | 2015-01-01 – 2015-12-31 | evidence 0001415889-16-004920 |
| FY 2014 | $-296.6k | 2014-01-01 – 2014-12-31 | evidence 0001415889-16-004920 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Panacea Life Sciences Holdings, Inc. — all facts · Revenue · Operating Income